Brief: Active Biotech Q2 EBIT Loss at SEK 10.7 Million
22/08/2024 07:34
Aug 22 (Reuters) - Active Biotech Q2 EBIT SEK -10.7 million. * Q2 net income SEK -10.6 million * Q2 EPS SEK -0.03
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million